Dr. Reddy's

Dr. Reddy's is one of the...

• Nifty 500.

Dr. Reddy's is a company listed under the stock ticker DRREDDY (IN).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

Acquisition, funding and merger involving Dr. Reddy's.

• Mayne Pharma US and Dr. Reddy's have announced they will merge  (posted on February 28 2023)..

View the org chart displaying its 41 main executives

Most searched biographies at Dr. Reddy's

• Erez Israeli, Chief Executive Officer
• Penny Wan, Director
• Satish Reddy, Co-Chairman of the Board

Popular executive movements at Dr. Reddy's

• Sanjiv Mehta has joined the company as Independent Director  (posted on January 3 2024).

Create your alert
to follow the executive moves at Dr. Reddy's.

Dr. Reddy's has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Dr. Reddy's

• Press Releases
• Dr. Reddy's in the news
• Press Releases
• Dr. Reddy's in the news
• Press Releases
• Press Releases
• Press Releases
• Press Releases
• View more press releases Close

Social media about Dr. Reddy's

• Dr. Reddy's on Wikipedia, Google News & Yahoo Finance
• Dr. Reddy's on LinkedIn, Twitter & YouTube

Contact by email its executives including Erez Israeli

Call Dr. Reddy's at +91 404...

View the org chart

Register to receive your alert

Report an error